Emerge Weight Loss Pricing (2026): Medication, Membership, and Total

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Emerge Weight Loss charges $224–$289 per month for compounded tirzepatide injection (4-week supply), depending on dose, and $149 per month for tirzepatide oral dissolving tablets. There is no membership fee, no signup fee, and no doctor visit charge; all prices are all-inclusive monthly rates. Emerge does not offer semaglutide, and the two highest injection doses (12.5 mg and 15 mg) are restricted to existing patients only. A maintenance plan—$49 supervision plus $99 medication—totals $148 per month for patients who reach goal weight. Over twelve months, total cost ranges from $1,776 (maintenance) to $3,468 (15 mg injection), with no prepayment required and no hidden fees.

Emerge Weight Loss pricing at a glance

Source: emergeweight.com/pricing, captured September 4, 2026. All prices are standard ongoing monthly rates; no membership fee, no signup fee, no shipping fee.

Breaking down Emerge's dose-tiered injection pricing

Emerge Weight Loss structures tirzepatide injection pricing by dose strength, with six tiers ranging from 2.5 mg to 15 mg. Each tier reflects a 4-week supply. The entry dose—2.5 mg—costs $224 per month, the mid-range 10 mg dose costs $269 per month, and the maximum 15 mg dose costs $289 per month. The highest two doses (12.5 mg and 15 mg) are available only to existing patients; new enrollees start at 10 mg or below.

This dose-dependent pricing means patients pay less early in treatment and more as they titrate upward. Over twelve months at a fixed dose, the cost spread is substantial: $2,688 at 2.5 mg versus $3,468 at 15 mg—a $780 annual difference. Patients who escalate dose mid-year will see their monthly bill increase by $10–$20 per tier.

Emerge's all-inclusive model bundles medication, provider supervision, and shipping into the single monthly charge. There is no separate membership fee, no per-visit charge, and no add-on for delivery.

Tirzepatide oral dissolving tablet: $149 per month

Emerge offers a tirzepatide oral dissolving tablet (ODT) at $149 per month for a 1-month supply. The published rate is labeled as a "starting price" in Emerge's terms, but no higher tier or dose-dependent pricing for the oral product was documented. The oral route avoids injection but uses the same compounded active ingredient as the injection product.

At $149 monthly, the ODT costs $75 less than Emerge's entry 2.5 mg injection and $140 less than the 15 mg injection. Over twelve months, the ODT totals $1,788, the lowest non-maintenance price in Emerge's catalog.

Maintenance plan: $148 per month

Patients who reach goal weight can transition to a maintenance plan priced at $148 per month, comprising $49 for clinical supervision and $99 for a medication vial (4-week supply). This plan is structured for patients who no longer require dose escalation and wish to sustain weight loss at a reduced cost. Over twelve months, the maintenance plan totals $1,776.

Emerge vs. PlexusDx: like-for-like tirzepatide injection comparison

PlexusDx charges $289 per month (month-to-month) for compounded tirzepatide injection at any dose—no tiers, no access restrictions. Comparing month-to-month plans:

PlexusDx pricing captured September 7, 2026; Emerge pricing captured September 4, 2026.

Emerge's savings over PlexusDx narrow as dose increases. At the entry 2.5 mg dose, Emerge costs $65 per month less than PlexusDx; at the maximum 15 mg dose, the two programs charge the same monthly rate. A patient who starts at 2.5 mg and titrates to 15 mg over six months will pay an Emerge total of approximately $1,614 for the first six months (averaging tiers 2.5–15 mg), compared to $1,734 on PlexusDx flat pricing—a modest $120 six-month difference that reflects Emerge's front-loaded savings.

PlexusDx offers longer-term prepaid plans that reduce the per-month equivalent: tirzepatide injection at $269 per month (prepaid 3-month plan, our calculation) or $249 per month (prepaid 6-month plan, our calculation). Comparing Emerge's month-to-month 10 mg rate ($269) to PlexusDx's prepaid 3-month equivalent ($269), the two are equal at that dose—but PlexusDx's rate stays flat across all doses, whereas Emerge's rate varies by tier.

Oral tirzepatide: Emerge ODT vs. PlexusDx capsules

Emerge's tirzepatide oral dissolving tablet costs $149 per month. PlexusDx offers compounded tirzepatide oral capsules at $349 per month (month-to-month). Over twelve months:

• Emerge ODT: $1,788 total
• PlexusDx oral capsules: $4,188 total
• Difference: Emerge is $200 per month ($2,400 per year) less expensive.

PlexusDx's oral tirzepatide price drops on prepaid plans: $299 per month (prepaid 3-month, our calculation) and $279 per month (prepaid 6-month, our calculation). Even at the lowest prepaid tier, PlexusDx oral costs $130 per month more than Emerge's ODT month-to-month rate.

The oral route avoids injection and may suit patients with needle aversion, but both Emerge and PlexusDx oral products are compounded formulations—not FDA-approved—and a licensed clinician must determine whether the route and dose are appropriate for the individual patient.

What Emerge includes (and omits)

Included in every Emerge plan

• Compounded tirzepatide medication (injection or oral)
• Provider supervision and prescription
• Shipping to the patient's address
• No membership fee, no signup fee, no per-visit charge

Not offered by Emerge

• Semaglutide: Emerge's catalog is tirzepatide-only; patients seeking semaglutide must consider other providers.
• High-dose access for new patients: The 12.5 mg and 15 mg injection doses are restricted to existing patients. New enrollees start at 10 mg or below and must titrate upward within the program before accessing higher tiers.

Decision factors: dose trajectory, medication choice, and access

Dose trajectory and cost visibility

Emerge's dose-tiered pricing delivers upfront savings for patients who start at lower doses, but it also means the monthly bill increases each time the prescriber raises the dose. A patient moving from 5 mg to 10 mg will see a $30 monthly increase ($239 → $269); a jump from 10 mg to 15 mg adds another $20 per month. For budgeting, this structure requires anticipating dose changes over time.

PlexusDx's flat $289 injection rate eliminates dose-driven cost variation. A patient who knows they will eventually reach 15 mg can lock in a single monthly figure from the start—or prepay a 6-month plan at $249 per month (our calculation) and avoid any mid-treatment price adjustment.

Semaglutide availability

Emerge does not offer semaglutide. Patients whose provider recommends semaglutide—whether for tolerability, insurance transition planning, or clinical preference—cannot fill that prescription through Emerge. PlexusDx offers compounded semaglutide injection at $189 per month (month-to-month) or $149 per month (prepaid 6-month, our calculation), giving patients access to both GLP-1 receptor agonist options under one program.

High-dose access restrictions

Emerge reserves its two highest injection doses (12.5 mg and 15 mg) for existing patients. A new patient cannot start treatment at 12.5 mg even if a prior provider prescribed that dose. This policy may complicate transfers for patients already stable on high-dose tirzepatide. PlexusDx places no access tier on any dose; a transferring patient can continue their current dose without interruption, subject to the prescribing clinician's independent assessment of appropriateness.

Oral vs. injection cost spread

Emerge's $149 ODT is the lowest-cost tirzepatide oral product documented in this comparison—$140 per month less than Emerge's own 15 mg injection and $200 per month less than PlexusDx's oral capsules. For patients who prefer or require the oral route and whose insurance does not cover branded tirzepatide, Emerge's ODT offers a material cost advantage. PlexusDx's oral capsules remain an option for patients who want a single provider for both injection and oral formulations, but at a higher monthly rate.

Choose Emerge Weight Loss if…

• You are starting tirzepatide at a low dose (2.5–5 mg) and want to pay less during the early titration phase—Emerge's entry pricing is $50–$65 per month below PlexusDx's flat injection rate.
• You prefer tirzepatide oral and cost is the decisive factor—Emerge's $149 ODT is $200 per month less than PlexusDx oral capsules and $130 per month less than PlexusDx's prepaid 6-month oral rate.
• You are comfortable with dose-tiered pricing and understand that your monthly cost will increase as your prescriber raises your dose.
• You have no need for semaglutide access and are confident tirzepatide is the right medication for your situation.

Choose PlexusDx if…

• You want cost certainty across every dose—PlexusDx charges $289 per month for tirzepatide injection whether you are on 2.5 mg or 15 mg, with no mid-treatment price increase.
• You are transferring from another provider at a high dose (12.5 mg or 15 mg) and want immediate access without an existing-patient requirement.
• You want the option to switch between semaglutide and tirzepatide under one provider—PlexusDx offers both at flat rates ($189/month for semaglutide injection, $289/month for tirzepatide injection, month-to-month).
• You prefer injection over oral and plan to prepay for cost savings—PlexusDx's 6-month prepaid tirzepatide injection plan costs $249 per month (our calculation), $20 less than Emerge's 15 mg month-to-month rate and $20 more than Emerge's 10 mg rate, with no tier jumps.
• You value month-to-month flexibility at the maximum dose with no price penalty—both Emerge and PlexusDx charge $289 per month at 15 mg, but PlexusDx charges that rate at every dose.

Methodology and freshness

Emerge Weight Loss pricing was captured from emergeweight.com/pricing on September 4, 2026 (13:49:55 UTC) and reflects the published rates for compounded tirzepatide injection (six dose tiers), oral dissolving tablet, and maintenance plan. PlexusDx pricing was captured on September 7, 2026 (10:28:56 UTC) from the PlexusDx alternatives page and represents month-to-month rates; prepaid per-month equivalents (3-month and 6-month plans) are our calculation based on PlexusDx's published total prepayment amounts. All 12-month totals are our calculation (monthly rate × 12). No promotional, introductory, or discount pricing was identified for Emerge; all figures are standard ongoing rates with no prepayment required. Readers should confirm current pricing, dose availability, and access restrictions at checkout, as telehealth pricing and policies can change.

Frequently Asked Questions

Does Emerge Weight Loss charge a membership fee?

No. Emerge Weight Loss does not charge a membership fee, signup fee, or per-visit consultation fee. The monthly medication price ($224–$289 for injection, $149 for oral) is all-inclusive and covers the prescription, provider supervision, medication, and shipping.

Why does Emerge's injection price increase with dose?

Emerge uses dose-tiered pricing, charging $224/month for 2.5 mg and $289/month for 15 mg. This structure reflects the cost of compounding higher-strength formulations. Patients pay less early in treatment and more as they titrate upward. PlexusDx charges one flat rate ($289/month for tirzepatide injection) regardless of dose.

Can I start Emerge at the 15 mg dose if I am transferring from another provider?

No. Emerge restricts the 12.5 mg and 15 mg injection doses to existing patients. New enrollees start at 10 mg or below and must titrate within the Emerge program before accessing higher tiers. PlexusDx places no access restriction on any dose, subject to the prescribing clinician's independent assessment.

Does Emerge offer semaglutide?

No. Emerge's catalog is limited to compounded tirzepatide (injection and oral dissolving tablet). Patients whose provider recommends semaglutide must seek care from another telehealth program. PlexusDx offers both semaglutide injection ($189/month) and tirzepatide injection ($289/month) under one provider.

How much does Emerge's tirzepatide oral product cost compared to PlexusDx oral tirzepatide?

Emerge charges $149/month for tirzepatide oral dissolving tablets. PlexusDx charges $349/month (month-to-month) or $279/month (prepaid 6-month, our calculation) for tirzepatide oral capsules. Emerge's ODT is $200/month less on a month-to-month basis and $130/month less than PlexusDx's lowest prepaid oral rate.

Sources

• Emerge Weight Loss pricing page (emergeweight.com/pricing), accessed September 4, 2026
• PlexusDx alternatives comparison page (plexusdx.com), accessed September 7, 2026
• PlexusDx Trustpilot profile, accessed September 4, 2026
• Verified research dataset: GLP1_Telehealth_Competitor_Research_20260904

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.